Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Mitra, Awarded

Jatin Mahajan (MD) conferred India?s Greatest Leader Award

10.10.2019 - 12:01:28

J Mitra & Co Awarded India?s Greatest Brand Award at the Asian Business & Social Summit 2019

Business Wire India
India’s leading in-vitro diagnostics company, J Mitra & Co has been conferred the title of India’s Greatest Brand 2018-19, and Jatin Mahajan, the managing director of the company has been conferred the title of India’s Greatest Leader 2018–19. The awards were given out to J Mitra and Company by Hon’ble Minister of State for Social Justice and Empowerment - Shri Ramdas Athawale at the Asian Business and Social Summit organised by AsiaOne & URS Media.

The high-level Business & Social Summit discussed and celebrated the emergence of India as a leading global economy, and notable Indian, Asian and world leaders were felicitated. The event was instrumental in bringing iconic, powerful, and emerging brands & leaders on a common platform.

Earlier, in July, J Mitra & Company was awarded for Innovation & Research in Healthcare at the 7th Global Healthcare Excellence Awards 2019. This prestigious award was given out to J Mitra & Co by the Hon’ble Minister of State for Health and Family Welfare Sri Ashwini Kr Choubey.

J Mitra & Co is a research-based biotechnology company that has been driving innovation in the healthcare (diagnostics) space since 1969. With over 55 patents to its credit which is the highest in its segment, J Mitra and Co has been constantly innovating to bring cost effective potent solutions for the global healthcare industry.

J Mitra’s latest innovation is India’s first portable diagnostic solution - the iQuant immunoassay analyzer. Launched in collaboration with IIT Madras’ HTIC (Healthcare Technology Innovation Centre), this portable state-of-the-art Fluorescence Immunoassay Analyzer provides quantitative and qualitative determination of blood test parameter – that includes TSH (Thyroid Stimulating Hormone), T3 (Tri-iodo thyronine), T4 (Thyroxin), Vitamin D, Dengue NS1 Antigen, Dengue IgM, Dengue IgG and HbA1c test. With this innovation, various highly-active and sought-after diagnostic solutions are now available across the country and in the remotest of locations at the fraction of a cost.

Speaking on the occasion, Jatin Mahajan, managing director, J Mitra said, “in line with government’s healthcare-for-all initiative.”

This is a home-grown innovative solution – a “completely Made-in-India” offering. While being the most cost-effective solution available in the market today, what sets it apart is the fact that it is completely portable. It can be carried with ease and has a self-sustaining power supply. It is thus quite suited for Indian conditions, especially for remote and electricity-dark areas.
About J Mitra & Co

Incorporated in 1969, this research-based biotechnology company has completed 50 years towards its mission to serve mankind. The company manufactures a range of tests for infectious diseases like HIV, HBV, HCV, Dengue, Malaria, Typhoid, Leptospira in rapid and ELISA test formats. The other products include a range of anti-Sera products and confirmatory tests like Western Blot for HIV.

Apart from a pan-India footprint, we are also the biggest exporter of diagnostics kits from India, and export to more than 45 countries across the entire globe.
 
@ businesswireindia.com